Corporate Banner
Satellite Banner
Pharma Outsourcing
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - May 2013


The 6th (2013) International Bio-pharmaceutical R&D Innovation Asia Summit

27 May 2013 - 29 May 2013 - Shanghai, China



Bookmark and Share


The 6th International Bio-pharmaceutical Industrial Development Innovation Forum & The 6th (2013) International Bio-pharmaceutical R&D Innovation Asia Summit will be held on May.27th-29th, 2012 in Shanghai, which organized by SEBMC, supported by International Alliance of Innovation Drug Research and European Association for Bio-industries and Biotechnology Industry Organization, at that time, more than 400 multinational pharmaceutical company leaders, global top level drug & medicine scientist and experts who from USA, Europe, China and Asia will join in this Forum, it will concern Bio-pharmaceutical, new drug research, innovative drug R&D outsourcing, pharmaceutical clinical research, translational medicine and personalized treatment technology, the Forum focus on new anticancer drugs, cardiovascular drugs, anti-diabetic drugs, neurodegenerative drugs, anti-infective drugs and resistance to major diseases drug innovation and clinical applications, antibody humanized technology and pharmaceutical technology invention, tumor molecular targeted drug development and targeted therapy technology, monoclonal antibody drug development and cell line development technology, Clinical Oncology Translational Medicine and individualized treatment, the forum will also explore that the Asian Pharmaceutical face the challenges of global blockbuster stage bio-pharmaceutical patents expiring peak, how to search for the production line of potential new drug development in Asia, how to control control the the new drug R&D investment and seek a reasonable balance during Drug Listing! Bring new drug development to maximize profits, to accelerate the transformation of drug R&D from the laboratory to clinical application, to search for future Asian new drug R&D trend and innovative model of win-win cooperation, to inject change drivers positive energy for the fast-growing Asian and emerging market R & D, to decode the Asian innovative drugs and translational medicine revolution, promote Asian new drug development and clinical medicine innovation. At the same time, The 6th (2013) International Bio-pharmaceutical and Biochemistry Instrument (Shanghai) Exhibition will be also held together, This exhibition will display comprehensively the Asian and international cutting-edge biomedical technology, the innovative biological products, laboratory equipment, clinical treatment and diagnostic testing equipment, diagnostic reagents and biochemical analysis equipment and other innovative products, this forum will be the most forefront event in Asian Pharmaceutical .



Further information
Scientific News
Investigational Malaria Vaccine Protects Healthy U.S. Adults
Researchers at NIH have found that the malaria vaccine protected a small number of healthy, malaria-naïve adults in the U.S. from infection for more than one year after immunization.
AACR 2016: Cancer Immunotherapy and Beyond
At this year's meeting there was a palpable buzz around subjects ranging from microbiomics to the tumor microenvironment and cancer vaccines, big data to in vitro and in vivo modeling and drug delivery (to name just a few).
New Database for Sharing MS Clinical Trial Data
A new database containing nearly 2500 patient records from the placebo arms of nine multiple sclerosis (MS) clinical trials is now available for research by qualified investigators.
Study Finds Factors That May Influence Influenza Vaccine Effectiveness
Researchers at NIH have suggested that the long-held approach to predicting seasonal influenza vaccine effectiveness may need to be revisited.
BMS’s Opdivo Clinical Trial Shows Promise
Safety profile of the combination regimen from CheckMate -069 was consistent with previously reported studies and adverse events were managed using established safety algorithms.
Treatment of Common Prostate Cancer
Researchers at UTSW have found that the prostate cancer treatments suppress immune response and may promote relapse.
Cancer Drug Could Treat Blood Vessel Deformities
A drug currently being trialled in cancer patients could also be used to treat an often incurable condition that can cause painful blood vessel overgrowths inside the skin.
Structure of Crucial Enzyme Identified
Researchers at UTSW have determined the atomic structure of an enzyme that plays an essential role in cell division and better treatment of cancer.
New Immunotherapy Trial for Type 1 Diabetes
The search for a treatment for Type 1 diabetes (T1D) - which affects over 400,000 people in the UK – will be stepped up with the start of a new phase one clinical trial at Guy’s Hospital in London.
Recruitment of First Patient in Clinical Study
Company has announced recruitment of first patient in clinical study assessing Visco-ease with Beatson Cancer Centre for the treatment of RIX.
Scroll Up
Scroll Down
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,100+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!